Summary:
If you are living with Crohn’s, our clinical research study may be for you.
Our team of medical professionals is evaluating an oral investigational drug called filgotinib to see if it reduces the signs and symptoms of Crohn’s disease by lowering the immune response that causes inflammation in the digestive system.
Qualified Participants Must:
• Try an oral investigational drug to see if it reduces the signs and symptoms of Crohn's disease Receive study drug and monitoring from a local study doctor at no cost
•
Be eligible to participate in a long-term extension study
Qualified Participants May Receive:
- Receive reimbursement for study-related travel expenses